These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 10348701

  • 1. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
    Jantzen HM, Gousset L, Bhaskar V, Vincent D, Tai A, Reynolds EE, Conley PB.
    Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
    [Abstract] [Full Text] [Related]

  • 2. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S, Schwarz TE, Patel ND, Craddock-Royal BD, Tagliente TM.
    Platelets; 2003 Jan; 14(7-8):445-62. PubMed ID: 14713514
    [Abstract] [Full Text] [Related]

  • 3. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
    Baurand A, Eckly A, Bari N, Léon C, Hechler B, Cazenave JP, Gachet C.
    Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
    [Abstract] [Full Text] [Related]

  • 4. Role of intracellular signaling events in ADP-induced platelet aggregation.
    Daniel JL, Dangelmaier C, Jin J, Kim YB, Kunapuli SP.
    Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
    [Abstract] [Full Text] [Related]

  • 5. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
    Fagura MS, Dainty IA, McKay GD, Kirk IP, Humphries RG, Robertson MJ, Dougall IG, Leff P.
    Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
    [Abstract] [Full Text] [Related]

  • 6. The P2Y1 receptor is essential for ADP-induced shape change and aggregation in mouse platelets.
    Kim YB, Jin J, Dangelmaier C, Daniel JL, Kunapuli SP.
    Platelets; 1999 May; 10(6):399-406. PubMed ID: 16801119
    [Abstract] [Full Text] [Related]

  • 7. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P, Hechler B, Gachet C, Breittmayer JP, Frelin C.
    Biochem Biophys Res Commun; 1999 Mar 05; 256(1):94-7. PubMed ID: 10066429
    [Abstract] [Full Text] [Related]

  • 8. Do heterotrimeric G proteins redistribute upon G protein-coupled receptor stimulation in platelets?
    Kahner BN, Quinton TM, Langan S, Kunapuli SP.
    Platelets; 2006 Sep 05; 17(6):397-404. PubMed ID: 16973501
    [Abstract] [Full Text] [Related]

  • 9. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.
    Hechler B, Léon C, Vial C, Vigne P, Frelin C, Cazenave JP, Gachet C.
    Blood; 1998 Jul 01; 92(1):152-9. PubMed ID: 9639511
    [Abstract] [Full Text] [Related]

  • 10. ADP-induced platelet activation.
    Puri RN, Colman RW.
    Crit Rev Biochem Mol Biol; 1997 Jul 01; 32(6):437-502. PubMed ID: 9444477
    [Abstract] [Full Text] [Related]

  • 11. ADP receptors of platelets and their inhibition.
    Gachet C.
    Thromb Haemost; 2001 Jul 01; 86(1):222-32. PubMed ID: 11487010
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway.
    Dangelmaier C, Jin J, Smith JB, Kunapuli SP.
    Thromb Haemost; 2001 Feb 01; 85(2):341-8. PubMed ID: 11246558
    [Abstract] [Full Text] [Related]

  • 13. Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism.
    Hardy AR, Hill DJ, Poole AW.
    Platelets; 2005 Nov 01; 16(7):415-29. PubMed ID: 16236603
    [Abstract] [Full Text] [Related]

  • 14. Platelet activation by ADP: the role of ADP antagonists.
    Gachet C.
    Ann Med; 2000 Dec 01; 32 Suppl 1():15-20. PubMed ID: 11209975
    [Abstract] [Full Text] [Related]

  • 15. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
    Jin J, Daniel JL, Kunapuli SP.
    J Biol Chem; 1998 Jan 23; 273(4):2030-4. PubMed ID: 9442040
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I.
    Pharmacol Ther; 2006 Jun 23; 110(3):415-32. PubMed ID: 16257449
    [Abstract] [Full Text] [Related]

  • 17. ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes--an effect selectively blocked by the thienopyridine clopidogrel.
    Gachet C, Savi P, Ohlmann P, Maffrand JP, Jakobs KH, Cazenave JP.
    Thromb Haemost; 1992 Jul 06; 68(1):79-83. PubMed ID: 1514178
    [Abstract] [Full Text] [Related]

  • 18. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.
    Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH.
    Nat Med; 1999 Oct 06; 5(10):1199-202. PubMed ID: 10502826
    [Abstract] [Full Text] [Related]

  • 19. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
    Maayani S, Schwarz T, Craddock-Royal B, Tagliente TM.
    Platelets; 2001 Sep 06; 12(6):359-75. PubMed ID: 11672475
    [Abstract] [Full Text] [Related]

  • 20. Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties?
    Baurand A, Eckly A, Hechler B, Kauffenstein G, Galzi JL, Cazenave JP, Léon C, Gachet C.
    Mol Pharmacol; 2005 Mar 06; 67(3):721-33. PubMed ID: 15602005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.